Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

230 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia.
Kollef M, Pittet D, Sánchez García M, Chastre J, Fagon JY, Bonten M, Hyzy R, Fleming TR, Fuchs H, Bellm L, Mercat A, Mañez R, Martínez A, Eggimann P, Daguerre M, Luyt CE; Prevention of Pneumonia Study (POPS-1) Trial Group. Kollef M, et al. Among authors: fleming tr. Am J Respir Crit Care Med. 2006 Jan 1;173(1):91-7. doi: 10.1164/rccm.200504-656OC. Epub 2005 Sep 28. Am J Respir Crit Care Med. 2006. PMID: 16192451 Clinical Trial.
A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy.
Giles FJ, Rodriguez R, Weisdorf D, Wingard JR, Martin PJ, Fleming TR, Goldberg SL, Anaissie EJ, Bolwell BJ, Chao NJ, Shea TC, Brunvand MM, Vaughan W, Petersen F, Schubert M, Lazarus HM, Maziarz RT, Silverman M, Beveridge RA, Redman R, Pulliam JG, Devitt-Risse P, Fuchs HJ, Hurd DD. Giles FJ, et al. Among authors: fleming tr. Leuk Res. 2004 Jun;28(6):559-65. doi: 10.1016/j.leukres.2003.10.021. Leuk Res. 2004. PMID: 15120931 Clinical Trial.
A phase III, randomized, double-blind, placebo-controlled, multinational trial of iseganan for the prevention of oral mucositis in patients receiving stomatotoxic chemotherapy (PROMPT-CT trial).
Giles FJ, Miller CB, Hurd DD, Wingard JR, Fleming TR, Sonis ST, Bradford WZ, Pulliam JG, Anaissie EJ, Beveridge RA, Brunvand MM, Martin PJ; PROMPT-CT Trial Investigators. Giles FJ, et al. Among authors: fleming tr. Leuk Lymphoma. 2003 Jul;44(7):1165-72. doi: 10.1080/1042819031000079159. Leuk Lymphoma. 2003. PMID: 12916869 Clinical Trial.
Safety and efficacy of ganaxolone in patients with CDKL5 deficiency disorder: results from the double-blind phase of a randomised, placebo-controlled, phase 3 trial.
Knight EMP, Amin S, Bahi-Buisson N, Benke TA, Cross JH, Demarest ST, Olson HE, Specchio N, Fleming TR, Aimetti AA, Gasior M, Devinsky O; Marigold Trial Group. Knight EMP, et al. Among authors: fleming tr. Lancet Neurol. 2022 May;21(5):417-427. doi: 10.1016/S1474-4422(22)00077-1. Lancet Neurol. 2022. PMID: 35429480 Clinical Trial.
The Case for Access to Data Monitoring Committee Charters.
Zarin D, Wittes JT, Fleming TR, Rockhold F, Ellenberg S, DeMets DL. Zarin D, et al. Among authors: fleming tr. NEJM Evid. 2024 Sep;3(9):EVIDctw2400058. doi: 10.1056/EVIDctw2400058. Epub 2024 Aug 27. NEJM Evid. 2024. PMID: 39189859 Review.
Moving forward in IPF: lessons learned from clinical trials.
Raghu G, Fleming TR. Raghu G, et al. Among authors: fleming tr. Lancet Respir Med. 2024 Aug;12(8):583-585. doi: 10.1016/S2213-2600(24)00177-2. Epub 2024 Jun 13. Lancet Respir Med. 2024. PMID: 38880115 No abstract available.
230 results